Pages that link to "Q37353099"

The following pages link to Advances in antifibrotic therapy (Q37353099):

Displaying 48 items.

• Withaferin-A reduces type I collagen expression in vitro and inhibits development of myocardial fibrosis in vivo (Q28482173) (← links)
• Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease (Q28534290) (← links)
• Ionone Derivatives from the Mycelium of Phellinus linteus and the Inhibitory Effect on Activated Rat Hepatic Stellate Cells (Q28833323) (← links)
• Current status of novel antifibrotic therapies in patients with chronic liver disease (Q30473375) (← links)
• Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice (Q34451277) (← links)
• A novel small compound that promotes nuclear translocation of YB-1 ameliorates experimental hepatic fibrosis in mice (Q34575731) (← links)
• Thymosin-β4 (Tβ4) Blunts PDGF-Dependent Phosphorylation and Binding of AKT to Actin in Hepatic Stellate Cells (Q34838683) (← links)
• Fusion protein of retinol-binding protein and albumin domain III reduces liver fibrosis (Q35695401) (← links)
• Loss of c-Met accelerates development of liver fibrosis in response to CCl4 exposure through deregulation of multiple molecular pathways (Q35918640) (← links)
• Tissue-type plasminogen activator suppresses activated stellate cells through low-density lipoprotein receptor-related protein 1 (Q36101672) (← links)
• Inverse Association of Plasma Level of Glutathione Peroxidase with Liver Fibrosis in Chronic Hepatitis B: Potential Role of Iron. (Q36948005) (← links)
• Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways (Q37112309) (← links)
• Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis (Q37164508) (← links)
• Retinol binding protein-albumin domain III fusion protein deactivates hepatic stellate cells (Q37462008) (← links)
• Proteomics and liver fibrosis: identifying markers of fibrogenesis (Q37579910) (← links)
• Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells (Q37619724) (← links)
• Hepatic inflammation and progressive liver fibrosis in chronic liver disease (Q37629675) (← links)
• Antifibrotic therapies--emerging biomarkers as treatment end points (Q37669172) (← links)
• Liver fibrosis in biliary atresia (Q37763083) (← links)
• Evolving challenges in hepatic fibrosis (Q37768335) (← links)
• Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve? (Q37897194) (← links)
• A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job. (Q38074884) (← links)
• Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis (Q38175465) (← links)
• miR‑203 inhibits the expression of collagen‑related genes and the proliferation of hepatic stellate cells through a SMAD3‑dependent mechanism (Q38701154) (← links)
• Functional Immune Anatomy of the Liver-As an Allograft (Q38723925) (← links)
• Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells (Q38793998) (← links)
• Targeting Hepatic Fibrosis in Autoimmune Hepatitis. (Q38902371) (← links)
• Diosmin attenuates radiation-induced hepatic fibrosis by boosting PPAR-γ expression and hampering miR-17-5p-activated canonical Wnt-β-catenin signaling. (Q38972122) (← links)
• Recombinant fusion protein of albumin-retinol binding protein inactivates stellate cells (Q39408392) (← links)
• Modulation of IKKβ/NF-κB and TGF-β1/Smad via Fuzheng Huayu recipe involves in prevention of nutritional steatohepatitis and fibrosis in mice. (Q40906850) (← links)
• Oxidative Stress and Hepatic Stellate Cells: A PARADOXICAL RELATIONSHIP. (Q41334406) (← links)
• Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo (Q41833192) (← links)
• Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice (Q42273298) (← links)
• Liver biopsy interpretation & the regression of hepatitis B virus related cirrhosis. (Q42971154) (← links)
• Letter: The reversal of liver cirrhosis--what we know and what we need to know--authors' reply (Q43534143) (← links)
• A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection (Q45361290) (← links)
• Anti-fibrotic effect of Cordyceps sinensis polysaccharide: Inhibiting HSC activation, TGF-β1/Smad signalling, MMPs and TIMPs (Q45368591) (← links)
• Experimental evidence for the therapeutic potential of tempol in the treatment of acute liver injury. (Q46431065) (← links)
• Angiotensin-converting enzyme inhibitor prevents oxidative stress, inflammation, and fibrosis in carbon tetrachloride-treated rat liver. (Q50261444) (← links)
• MR Imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-targeted ultrasmall superparamagnetic iron oxide (Q50441063) (← links)
• Protein S is protective in pulmonary fibrosis. (Q53102309) (← links)
• Inhibitory effects of Scutellaria baicalensis extract on hepatic stellate cells through inducing G2/M cell cycle arrest and activating ERK-dependent apoptosis via Bax and caspase pathway (Q53194964) (← links)
• Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease. (Q55223200) (← links)
• PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis (Q59357241) (← links)
• On the reversal of liver cirrhosis: mystery or reality? (Q83959649) (← links)
• New therapeutic aspect for carvedilol: Antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage (Q84031150) (← links)
• Dynamic Changes in Function and Proteomic Composition of Extracellular Vesicles from Hepatic Stellate Cells during Cellular Activation (Q93006500) (← links)
• Extracellular Vesicles From Hepatocytes Are Therapeutic for Toxin-Mediated Fibrosis and Gene Expression in the Liver (Q93054893) (← links)